ReP USP - Resultado da busca

Artigo de periodico
The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation (2022)
Cambui, Raylane Adrielle Gonçalves ; Fernandes, Fernanda Pereira; Leal, Vinicius Nunes Cordeiro ; Reis, Edione Cristina dos ; Lima, Dhemerson Souza de ; Santo, Gilmar Ferreira do Espírito ; Elias, Rosa Maria ; Pontillo, Alessandra
Fonte: Journal of Cancer Research and Clinical Oncology. Unidade: ICB
Assuntos: IMUNOLOGIA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, CÉLULAS CULTIVADAS DE TUMOR, VARIAÇÃO GENÉTICA, COMPLEXOS MULTIENZIMÁTICOS, NUCLEOTÍDEOS, NEOPLASIAS DO COLON, ESTUDOS DE COORTES, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMBUI, Raylane Adrielle Gonçalves et al. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. Journal of Cancer Research and Clinical Oncology, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00432-022-04284-8. Acesso em: 26 out. 2025.
APA
Cambui, R. A. G., Fernandes, F. P., Leal, V. N. C., Reis, E. C. dos, Lima, D. S. de, Santo, G. F. do E., et al. (2022). The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. Journal of Cancer Research and Clinical Oncology, 1-10. doi:10.1007/s00432-022-04284-8
NLM
Cambui RAG, Fernandes FP, Leal VNC, Reis EC dos, Lima DS de, Santo GF do E, Elias RM, Pontillo A. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation [Internet]. Journal of Cancer Research and Clinical Oncology. 2022 ; 1-10.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-022-04284-8
Vancouver
Cambui RAG, Fernandes FP, Leal VNC, Reis EC dos, Lima DS de, Santo GF do E, Elias RM, Pontillo A. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation [Internet]. Journal of Cancer Research and Clinical Oncology. 2022 ; 1-10.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-022-04284-8
Artigo de periodico
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) (2020)
Soares, Andrey; Monteiro, Fernando Sabino Marques; Maluf, Fernando Cotait; Bastos, Diogo Assed; Jardim, Denis Leonardo; Sasse, Andre Deeke; Silva, Adriano Gonçalves e; Fay, André P; Rosa, Diogo Augusto Rodrigues da; Wierman, Evanius; Kater, Fabio; Schutz, Fabio A.; Oliveira, Fernando Nunes Galvão de; Morbeck, Igor Alexandre Protzner; Rinck, José Augusto; Trindade, Karine Martins da; Maia, Manuel Caitano; Souza, Vinicius Carrera; Silva Neto, Deusdedit Cortez Vieira da; Paula, Felipe de Almeida e; Korkes, Fernando; Carvalhal, Gustavo Franco; Nogueira, Lucas; Fernandes, Roni de Carvalho; Reis, Rodolfo Borges dos ; Matheus, Wagner Eduardo; Busato Júnior, Wilson Francisco Schreiner; Costa, Walter Henriques da; Zequi, Stênio de Cássio
Fonte: Journal of Cancer Research and Clinical Oncology. Unidades: FMRP, FM
Assuntos: CARCINOMA, RIM, NEFRECTOMIA, IMUNOTERAPIA, NEOPLASIAS RENAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Andrey et al. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG). Journal of Cancer Research and Clinical Oncology, v. 146, n. 7, p. 1829-1845, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00432-020-03236-4. Acesso em: 26 out. 2025.
APA
Soares, A., Monteiro, F. S. M., Maluf, F. C., Bastos, D. A., Jardim, D. L., Sasse, A. D., et al. (2020). Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG). Journal of Cancer Research and Clinical Oncology, 146( 7), 1829-1845. doi:10.1007/s00432-020-03236-4
NLM
Soares A, Monteiro FSM, Maluf FC, Bastos DA, Jardim DL, Sasse AD, Silva AG e, Fay AP, Rosa DAR da, Wierman E, Kater F, Schutz FA, Oliveira FNG de, Morbeck IAP, Rinck JA, Trindade KM da, Maia MC, Souza VC, Silva Neto DCV da, Paula F de A e, Korkes F, Carvalhal GF, Nogueira L, Fernandes R de C, Reis RB dos, Matheus WE, Busato Júnior WFS, Costa WH da, Zequi S de C. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) [Internet]. Journal of Cancer Research and Clinical Oncology. 2020 ; 146( 7): 1829-1845.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-020-03236-4
Vancouver
Soares A, Monteiro FSM, Maluf FC, Bastos DA, Jardim DL, Sasse AD, Silva AG e, Fay AP, Rosa DAR da, Wierman E, Kater F, Schutz FA, Oliveira FNG de, Morbeck IAP, Rinck JA, Trindade KM da, Maia MC, Souza VC, Silva Neto DCV da, Paula F de A e, Korkes F, Carvalhal GF, Nogueira L, Fernandes R de C, Reis RB dos, Matheus WE, Busato Júnior WFS, Costa WH da, Zequi S de C. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) [Internet]. Journal of Cancer Research and Clinical Oncology. 2020 ; 146( 7): 1829-1845.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-020-03236-4
Artigo de periodico
Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells (2012)
Borges, Kleiton Silva; Gamero, Angel Mauricio Castro; Moreno, Daniel Antunes; Silveira, Vanessa da Silva; Brassesco, Maria Sol; Queiroz, Rosane Gomes de Paula; Oliveira, Harley Francisco de; Carlotti Júnior, Carlos Gilberto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Journal of Cancer Research and Clinical Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, PROTEÍNAS QUINASES, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton Silva et al. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, v. 138, n. 3, p. 405-414, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00432-011-1111-0. Acesso em: 26 out. 2025.
APA
Borges, K. S., Gamero, A. M. C., Moreno, D. A., Silveira, V. da S., Brassesco, M. S., Queiroz, R. G. de P., et al. (2012). Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, 138( 3), 405-414. doi:10.1007/s00432-011-1111-0
NLM
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Vancouver
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Artigo de periodico
Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial (2011)
Mattar, Andre; Logullo, Angela Flávia; Facina, Gil; Nonogaki, Suely; Soares, Fernando Augusto; Gebrim, Luiz Henrique
Fonte: Journal of Cancer Research and Clinical Oncology. Unidade: FO
Assuntos: NEOPLASIAS BUCAIS, NEOPLASIAS, HORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTAR, Andre et al. Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial. Journal of Cancer Research and Clinical Oncology, v. 137, n. 5, p. 897-905, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00432-010-0950-4. Acesso em: 26 out. 2025.
APA
Mattar, A., Logullo, A. F., Facina, G., Nonogaki, S., Soares, F. A., & Gebrim, L. H. (2011). Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial. Journal of Cancer Research and Clinical Oncology, 137( 5), 897-905. doi:10.1007/s00432-010-0950-4
NLM
Mattar A, Logullo AF, Facina G, Nonogaki S, Soares FA, Gebrim LH. Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial [Internet]. Journal of Cancer Research and Clinical Oncology. 2011 ; 137( 5): 897-905.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-010-0950-4
Vancouver
Mattar A, Logullo AF, Facina G, Nonogaki S, Soares FA, Gebrim LH. Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial [Internet]. Journal of Cancer Research and Clinical Oncology. 2011 ; 137( 5): 897-905.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/s00432-010-0950-4
Artigo de periodico
International symposium on new leads in experimental and clinical gene targeting in cancer (2003)
Zanker, K. S.; Brentani, R.; Mihich, E.
Fonte: Journal of Cancer Research and Clinical Oncology. Unidade: FM
Assuntos: GENES, CONFERÊNCIA INTERNACIONAL, NEOPLASIAS (GENÉTICA), GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANKER, K. S. e BRENTANI, R. e MIHICH, E. International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology, v. 129, p. 258-261, 2003Tradução . . Acesso em: 26 out. 2025.
APA
Zanker, K. S., Brentani, R., & Mihich, E. (2003). International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology, 129, 258-261.
NLM
Zanker KS, Brentani R, Mihich E. International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology. 2003 ; 129 258-261.[citado 2025 out. 26 ]
Vancouver
Zanker KS, Brentani R, Mihich E. International symposium on new leads in experimental and clinical gene targeting in cancer. Journal of Cancer Research and Clinical Oncology. 2003 ; 129 258-261.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Aerobic capacity and muscle strength in malnourished cancer patients (1990)
Leme, R B A; Dias, M. C. G.; Battaglia, C; Libanori, H T; Maluf, F; Faintuch, B L; Faintuch, Joel; Pinotti, Henrique Walter
Fonte: Journal of Cancer Research and Clinical Oncology. Nome do evento: International Cancer Congress. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEME, R B A et al. Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 1990
APA
Leme, R. B. A., Dias, M. C. G., Battaglia, C., Libanori, H. T., Maluf, F., Faintuch, B. L., et al. (1990). Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. Faculdade de Medicina, Universidade de São Paulo.
NLM
Leme RBA, Dias MCG, Battaglia C, Libanori HT, Maluf F, Faintuch BL, Faintuch J, Pinotti HW. Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Vancouver
Leme RBA, Dias MCG, Battaglia C, Libanori HT, Maluf F, Faintuch BL, Faintuch J, Pinotti HW. Aerobic capacity and muscle strength in malnourished cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Trabalho de evento-resumo periodico
Modified parenteral nutrition in weight-losing cancer patients (1990)
Faintuch, B L; Faintuch, Joel; Ribeiro Junior, U; Gama Rodrigues, Joaquim José; Pinotti, Henrique Walter
Fonte: Journal of Cancer Research and Clinical Oncology. Nome do evento: International Cancer Congress. Unidade: FM
Assunto: NUTRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAINTUCH, B L et al. Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 26 out. 2025. , 1990
APA
Faintuch, B. L., Faintuch, J., Ribeiro Junior, U., Gama Rodrigues, J. J., & Pinotti, H. W. (1990). Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. Faculdade de Medicina, Universidade de São Paulo.
NLM
Faintuch BL, Faintuch J, Ribeiro Junior U, Gama Rodrigues JJ, Pinotti HW. Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Vancouver
Faintuch BL, Faintuch J, Ribeiro Junior U, Gama Rodrigues JJ, Pinotti HW. Modified parenteral nutrition in weight-losing cancer patients. Journal of Cancer Research and Clinical Oncology. 1990 ;116( supl. pt.1): 642.[citado 2025 out. 26 ]
Artigo de periodico
Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice (1985)
Barretto, Orlando César de Oliveira; Zyngier, Szulim Ber
Fonte: Journal of Cancer Research and Clinical Oncology. Unidades: ICB, FM
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARRETTO, Orlando César de Oliveira e ZYNGIER, Szulim Ber. Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice. Journal of Cancer Research and Clinical Oncology, v. 110, p. 247-248, 1985Tradução . . Disponível em: https://doi.org/10.1007/bf00399283. Acesso em: 26 out. 2025.
APA
Barretto, O. C. de O., & Zyngier, S. B. (1985). Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice. Journal of Cancer Research and Clinical Oncology, 110, 247-248. doi:10.1007/bf00399283
NLM
Barretto OC de O, Zyngier SB. Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice [Internet]. Journal of Cancer Research and Clinical Oncology. 1985 ; 110 247-248.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/bf00399283
Vancouver
Barretto OC de O, Zyngier SB. Qualitative erythrocyte enzymatic disorder in ehrlich tumor-baaring in mice [Internet]. Journal of Cancer Research and Clinical Oncology. 1985 ; 110 247-248.[citado 2025 out. 26 ] Available from: https://doi.org/10.1007/bf00399283

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada